Indivior Pharmaceuticals, Inc. INDV Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $175M-53.0% | $195M-38.9% | $445M+54.5% | $510M— | $372M— | ||
| $1.03B+106% | $995M+296% | $996M+297% | $728M+171% | $498M+86.9% | ||
| $21M-41.7% | $32M-37.3% | $40M-76.0% | $45M-72.3% | $36M-76.9% | ||
| $667M— | $652M— | $922M— | —— | —— | ||
| $157M— | $144M— | $124M— | —— | —— | ||
| $2M— | $2M— | $2M— | —— | —— | ||
| $1.2B— | $1.2B— | $1.42B— | —— | —— | ||
| $35M— | $48M— | $41M— | —— | —— | ||
| $0— | $29M— | $18M— | —— | —— | ||
| $779M— | $914M— | $965M— | —— | —— | ||
| $486M— | $290M— | $304M— | —— | —— | ||
| $1.34B— | $1.3B— | $1.62B— | —— | —— | ||
| $0— | $62M— | $62M— | —— | —— | ||
| -$280M— | -$243M— | -$346M— | —— | —— | ||
| -$144M+49.5% | -$98M+70.9% | -$207M+33.2% | -$257M— | -$285M— | ||
| $1.2B— | $1.2B— | $1.42B— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Indivior Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 0.86 — current liabilities exceed current assets.
- Where does Indivior Pharmaceuticals, Inc. 's balance sheet data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.